Actively Recruiting
Integrated TCM - Western Medicine Strategy for Long - Distance Diabetes Management
Led by Shanxi Bethune Hospital · Updated on 2025-12-04
10000
Participants Needed
1
Research Sites
30 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The management of diabetes is of great value in reducing the risk of complications and alleviating the socioeconomic burden. Currently, the diabetes management models in China have not effectively integrated the advantages of traditional Chinese medicine (TCM) and Western medicine. They also fail to achieve intelligent and automated management, resulting in high management costs and low efficiency. Therefore, it is extremely urgent to explore a new, efficient, convenient, low - cost, and personalized long - distance, full - course, intelligent management model for diabetes that integrates TCM and Western medicine both online and offline. Based on this, our research group plans to rely on the pre - designed and developed Idata database. We will deeply integrate the diagnostic and treatment advantages of TCM constitution differentiation and Western medical examinations and laboratory tests, construct an automated follow - up path, and build an integrated online diabetes management platform for Internet hospitals, which consists of "intelligent hardware + APP + cloud services + a back - end think - tank of TCM and Western medicine experts + a back - end professional management and care team". This initiative aims to blaze a new trail in the field of long - distance, full - course, and personalized management of diabetes through the synergy of TCM and Western medicine for Chinese diabetes patients. We expect to significantly reduce the incidence of diabetes complications, remarkably improve the overall health status and quality of life of patients, and bring unprecedented positive impacts on the well - being of diabetes patients.
CONDITIONS
Official Title
Integrated TCM - Western Medicine Strategy for Long - Distance Diabetes Management
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Presence of typical diabetes symptoms (frequent urination, increased thirst, increased hunger, unexplained weight loss) and one of the following: fasting venous plasma glucose ≥ 7.0 mmol/L, random plasma glucose ≥ 11.1 mmol/L, or glycated hemoglobin (HbA1c) ≥ 6.5%
- Or, meeting oral glucose tolerance test criteria: fasting plasma glucose ≥ 7.0 mmol/L and 2-hour plasma glucose ≥ 11.1 mmol/L after a 75g glucose load
You will not qualify if you...
- Having other serious health conditions that may prevent following the study plan, such as active cancer, rheumatic autoimmune diseases, severe infections, multiple organ failure, or psychiatric disorders
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Shanxi Bethune Hospital
Taiyuan, Shanxi, China, 030000
Actively Recruiting
Research Team
S
Shiwei Liu, Doctor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here